New vaccine trial reduces malaria by one-third in African infants
Latest vaccine trial results show a reduction in malaria by approximately one-third in African infants aged 6 to 12 weeks – lower than that seen in the older age group a year ago.
Read Full Story
Advertise Here contact ads[@]ghheadlines.com
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS